MOR - MorphoSys expects a 5% surge in Monjuvi sales for Q3
2023-10-25 05:54:08 ET
More on MorphoSys
- MorphoSys: Pelabresib Data Coming Out Soon, More Room To Run
- MorphoSys: Stable Liquidity Amid Challenging Markets
- Seeking Alpha’s Quant Rating on MorphoSys
- Historical earnings data for MorphoSys
For further details see:
MorphoSys expects a 5% surge in Monjuvi sales for Q3